Job Detail

Director, Compound Development Te

Inseriert am: 01.10.2019



As part of the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We collaborate with the world for the health of everyone in it.
Actelion is a leader in the field of pulmonary arterial hypertension (PAH). Our portfolio of PAH treatments covers the spectrum of disease, from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications.
Director Compound Development


The position leads the global clinical development of early and late stage development assets within the portfolio of the Therapeutic Area as well as post-market activities, in alignment with the wider R&D and commercial strategies, to meet the target product profile.

 

Leading one or multiple cross-functional “Clinical Development Teams” (CDTs) in a matrix organization, the position drives the development activities throughout the lifecycle of the compound from the definition of the clinical development and clinical trial strategies up through to the submission to health authorities for market approval, in alignment with the CDTL responsible for the compound. It further works closely with the commercial function on post-marked clinical activities.

 

The position holder is a member of the Clinical Development Leadership Team (CDTL) for the Therapeutic Area.


Major responsibilities:



  • In close alignment with the CDTL responsible for the compound, lead the design and execution of the cross-functional clinical development strategy for designated compound(s) to meet the target product profile/quality standards, obtain regulatory approval, demonstrate value and achieve target reimbursement


  • Lead the ongoing adjustment and optimization of the clinical development strategy along the lifecycle of the compound, factoring in clinical/medical, financial, policy, regulatory and any other relevant external factors, in order to maximize the full potential of the asset.


  • Organize and lead the “Clinical Development Team” (CDT) - in a matrix organization including functional representatives from Commercial, Market Access, Clinical Science, Regulatory Affairs, Technical Operations, Program Management, Quantitative Sciences, and Legal - to drive the compound’s clinical development activities and enable an effective strategy planning and decision-making process.


  • Represent the CDT towards senior leadership and in governance bodies within PHTA (CDLT, APLT) and in the wider R&D organization (Development Committee, Investment Committee, etc.) in order to achieve strategic alignment and approval for the clinical development activities


  • Proactively anticipate strategic and operational risks to the programs, address these to the relevant functional stakeholders, and ensure their mitigation or resolution


  • Champion the product at all levels of the organization, while bringing the wider portfolio perspective and R&D and Commercial strategies to the CDT.


  • Contribute to the professional development of CDT members, proving feedback, coaching and suggesting personal development actions


  • Ensure robust and strategically aligned publications, IIS, clinical trial and RWE initiatives globally


  • Support regulatory submission activities in order to obtain regulatory approval.


  • Drive and maintain external alliances for partnered products.



Qualifications



  • >10 years in pharmaceutical industry; thereof >5 years in clinical development

  • Doctorate (PhD, PharmD) in Lifesciences, Medicine, Biology, Chemistry, or related area

  • Academic and/or pharmaceutical industry experience in drug development.

  • Deep understanding of the scientific/disease areas, the compound’s/product’s clinical utility and expertise in current and innovative therapeutic development paradigms (e.g. drugs, devices, diagnostics, prevention)

  • Knowledge of clinical development processes, clinical trial processes, and regulatory requirements/guidelines

  • Experience managing scientific programs/projects.

  • Track record of delivering results for complex projects, extensive collaborative partnerships, and in implementing new approached in response to/anticipation of changing environments

  • Experience working with medical and scientific personnel in the pharmaceutical industry

  • Experience working with cross-functional (R&D and Commercial) teams in a matrix organization.

  • Strategic Thinking: Assesses the wider corporate and external environmental context and how this impact the portfolio; Translates scientific and business concepts into long- and short-term objectives and deliverables; Manages ambiguity and risk

  • Communication/Negotiation: Influences and builds consensus on CDT strategies and objectives; Enables timely and appropriate information-flows to stakeholders in- and outside the CDT; Represents the organization towards external stakeholders

  • Team leadership: Motivates teams, builds cohesion, and ensures resilience and positivity under pressure; Recognizes and resolves conflicts; Coaches & builds high performing teams; Fosters a credo-based mindset

  • Technical: Excellent user of computer systems and software; Excellent MS Office skills

  • Languages: English (fluent)


Primary Location

Switzerland-Allschwil--


Organization

Actelion Pharmaceuticals Ltd (Swiss Confederation) (8542)


Job Function

R&D


Requisition ID

1905769178W

Details